Detection rate and prognostic value of circulating tumor cells and circulating tumor DNA in metastatic uveal melanoma
- PMID: 23934701
- DOI: 10.1002/ijc.28436
Detection rate and prognostic value of circulating tumor cells and circulating tumor DNA in metastatic uveal melanoma
Abstract
Circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) have been recently investigated in several cancer types, but their respective clinical significance remains to be determined. In our prospective study, we compared the detection rate and the prognostic value of these two circulating biomarkers in patients with metastatic uveal melanoma. GNAQ/GNA11 mutations were characterized in archived tumor tissue. Using a highly sensitive and mutation-specific bidirectional pyrophosphorolysis-activated polymerization (bi-PAP) technique, GNAQ c.626A>T, GNAQ c.626A>C and GNA11 c.626A>T copy numbers were quantified in plasma from 12 mL of blood. CTCs were detected at the same time in 7.5 mL of blood by the CellSearch technique. Patient characteristics and outcome were prospectively collected. CTCs (≥1) were detected in 12 of the 40 included patients (30%, range 1-20). Among the 26 patients with known detectable mutations, ctDNA was detected and quantified in 22 (84%, range 4-11,421 copies/mL). CTC count and ctDNA levels were associated with the presence of miliary hepatic metastasis (p = 0.004 and 0.03, respectively), with metastasis volume (p = 0.005 and 0.004) and with each other (p < 0.0001). CTC count and ctDNA levels were both strongly associated with progression-free survival (p = 0.003 and 0.001) and overall survival (p = 0.0009 and <0.0001). In multivariate analyses, ctDNA appeared to be a better prognostic marker than CTC. In conclusion, ctDNA and CTC are correlated and both have poor prognostic significance. CTC detection can be performed in every patient but, in patients with detectable mutations, ctDNA was more frequently detected than CTC and has possibly more prognostic value.
Keywords: circulating tumor DNA; circulating tumor cells; metastasis; uveal melanoma.
© 2013 UICC.
Similar articles
-
Oncogenic GNAQ and GNA11 mutations in uveal melanoma in Chinese.PLoS One. 2014 Oct 3;9(10):e109699. doi: 10.1371/journal.pone.0109699. eCollection 2014. PLoS One. 2014. PMID: 25280020 Free PMC article.
-
Genetic and clinico-pathologic analysis of metastatic uveal melanoma.Mod Pathol. 2014 Feb;27(2):175-83. doi: 10.1038/modpathol.2013.138. Epub 2013 Jul 26. Mod Pathol. 2014. PMID: 23887304
-
Ultradeep sequencing detects GNAQ and GNA11 mutations in cell-free DNA from plasma of patients with uveal melanoma.Cancer Med. 2013 Apr;2(2):208-15. doi: 10.1002/cam4.61. Epub 2013 Feb 14. Cancer Med. 2013. PMID: 23634288 Free PMC article.
-
GNAQ and GNA11 mutations in uveal melanoma.Melanoma Res. 2014 Dec;24(6):525-34. doi: 10.1097/CMR.0000000000000121. Melanoma Res. 2014. PMID: 25304237 Review.
-
Research in practice: Therapeutic targeting of oncogenic GNAQ mutations in uveal melanoma.J Dtsch Dermatol Ges. 2020 Nov;18(11):1245-1248. doi: 10.1111/ddg.14288. Epub 2020 Sep 21. J Dtsch Dermatol Ges. 2020. PMID: 32954611 Review.
Cited by
-
The Promise of Circulating Tumor DNA in Head and Neck Cancer.Cancers (Basel). 2022 Jun 16;14(12):2968. doi: 10.3390/cancers14122968. Cancers (Basel). 2022. PMID: 35740633 Free PMC article. Review.
-
Genome-wide copy number alteration and VEGFA amplification of circulating cell-free DNA as a biomarker in advanced hepatocellular carcinoma patients treated with Sorafenib.BMC Cancer. 2019 Apr 1;19(1):292. doi: 10.1186/s12885-019-5483-x. BMC Cancer. 2019. PMID: 30935424 Free PMC article.
-
Analysis of Circulating Tumour Cells in Early-Stage Uveal Melanoma: Evaluation of Tumour Marker Expression to Increase Capture.Cancers (Basel). 2021 Nov 28;13(23):5990. doi: 10.3390/cancers13235990. Cancers (Basel). 2021. PMID: 34885099 Free PMC article.
-
Blood Biomarkers of Uveal Melanoma: Current Perspectives.Clin Ophthalmol. 2020 Jan 20;14:157-169. doi: 10.2147/OPTH.S199064. eCollection 2020. Clin Ophthalmol. 2020. PMID: 32021081 Free PMC article. Review.
-
Pilot Study of Circulating Tumor Cells in Early-Stage and Metastatic Uveal Melanoma.Cancers (Basel). 2019 Jun 20;11(6):856. doi: 10.3390/cancers11060856. Cancers (Basel). 2019. PMID: 31226786 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials